The court held that there are long-term risks and consequences from the administration of puberty blockers and the clinical interventions being made, and "given that the treatment is as yet innovative and experimental, we recognise that clinicians may well regard these as cases where the authorisation of the court should be sought prior to commencing the clinical treatment.". The court decided that under-13s were "highly unlikely" to be able to consent to blockers. At ages 14 and 15, it was "[still] doubtful", and at 16 and 17, the courts should still decide.